Simplex Trading, LLC Oric Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$5.41 - $9.43 $881 - $1,537	163 New	163 $1,000
Q2 2023 Aug 04, 2023	BUY	$4.95 - $8.4 $141,718 - $240,492	28,630 Added 7397.93%	29,017 $225,000
Q1 2023 Apr 27, 2023	SELL	$4.26 - $6.75 $16,175 - $25,629	-3,797 Reduced 90.75%	387 $2,000
Q4 2022 Feb 02, 2023	SELL	$2.41 - $5.89 $14,308 - $34,968	-5,937 Reduced 58.66%	4,184 $24,000
Q3 2022 Nov 04, 2022	BUY	$3.15 - $5.24 $5,745 - $9,557	1,824 Added 21.98%	10,121 $32,000
Q2 2022 Aug 03, 2022	BUY	$2.7 - $7.07 $17,401 - $45,566	6,445 Added 348.0%	8,297 $37,000
Q1 2022 May 02, 2022	BUY	$4.54 - $16.1 $7,881 - $27,949	1,736 Added 1496.55%	1,852 $9,000
Q2 2021 Aug 12, 2021	BUY	$17.37 - $25.34 $2,014 - $2,939	116 New	116 $2,000

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.